Saturn V Capital Management »

Dyne Therapeutics shares owned by Saturn V Capital Management

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Saturn V Capital Management from 13F filings

Historical chart of Saturn V Capital Management investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Saturn V Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Saturn V Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $34M 2.7M 12.65
2025-06-30 $14M 1.5M 9.52

More positions owned by Saturn V Capital Management

Abivax Sa Sponsored Ads (ABVX)
Amylyx Pharmaceuticals (AMLX)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Dyne Therapeutics (DYN)
Cogent Biosciences (COGT)
Vaxcyte (PCVX)
Celcuity (CELC)
Cg Oncology (CGON)
Disc Medicine (IRON)
Pharvaris N V (PHVS)
Xenon Pharmaceuticals (XENE)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Merus N V (MRUS)
Lenz Therapeutics (LENZ)
Ocular Therapeutix (OCUL)

View all positions for Saturn V Capital Management

Top funds holding Dyne Therapeutics

Henderson Group
Vanguard Group
BlackRock
Atlas Venture Life Science Advisors
Fcpm Iii Services B.v.
FMR
State Street Corporation
Siren
TCG Crossover Management
Adage Capital Partners GP
Citadel Advisors
Jpmorgan Chase & Co
Armistice Capital
Marshall Wace
Rtw Investments

View all funds holding Dyne Therapeutics